| Net Cash Provided by (Used in) Operating Activities |
$19,218,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$21,068,000 |
USD |
-334% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
620,931 |
shares |
7.1% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,850,000 |
USD |
-310% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$5,315,000 |
USD |
14% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$1,848,000 |
USD |
-10% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$605,520,000 |
USD |
6.7% |
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
$656,916,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Interest Expense |
$7,142,000 |
USD |
56% |
Q2 2024 |
Q2 2024 |